NOVATO, California., and LONDON, January 22 /PRNewswire/ --

BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that it has appointed Mr. Steve Glass as Vice President and General Manager of European Operations. BioMarin Europe Ltd., headquartered in London, is responsible for the sales and distribution of Naglazyme(R) for MPS VI (mucopolysaccharidosis VI) in Europe. Mr. Glass is the former General Manager for Altana/Nycomed, France. He has replaced former Vice President and General Manager, William Aliski who played an instrumental role in the successful launch of Naglazyme in Europe and the establishment of BioMarin's first international commercial operation.

RAMAT GAN, Israel, January 22 /PRNewswire/ --

- Simple, Accurate and Flexible Comparison, Synchronization and Replication Across any Database

DBBalance the leading provider of database data and structure comparison, synchronization and migration solutions has released version 6.0 of the Cross Database suite of products. Serving hundreds of customers, DBBalance is committed to providing state of the art solutions for developers, DBAs and IT managers. The new version includes significant improvements in performance, ease of use and enhanced security. Version 6.0 includes the following improvements:

- Enhanced performance

- Build in award winning set of ODBC drivers

- Multi-transaction mode

- Database structure Filters

A good fight with your spouse may be good for your health, research suggests.

Couples in which both the husband and wife suppress their anger when one attacks the other die earlier than members of couples where one or both partners express their anger and resolve the conflict, according to preliminary results of a University of Michigan study.

Researchers looked at 192 couples over 17 years and placed the couples into one of four categories: both partners communicate their anger; in the second and third groups one spouse expresses while the other suppresses; and both the husband and wife suppress their anger and brood, said Ernest Harburg, professor emeritus with the U-M School of Public Health and the Psychology Department, and lead author.

LOS ANGELES, January 22 /PRNewswire/ --

- Mike Franzino to Take on Global Role

MOSCOW, January 22 /PRNewswire/ --

Mechel OAO (NYSE: MTL), one of the leading Russian mining and metals companies, announces the appointment of Stanislav Ploschenko as its Chief Financial Officer effective immediately.

Previously, Mr. Ploschenko (31) was Mechel OAO's Acting Chief Financial Officer. As Chief Financial Officer, he will continue to be responsible for strategic development of Mechel's Finance Division, financial policies and planning, US GAAP reporting, implementation of internal controls, integration and unification of Mechel subsidiaries' operations, and operational management of the financial units.

ST. DAVID'S, Bermuda, January 22 /PRNewswire/ --

Warner Chilcott Limited (Nasdaq: WCRX) announced today that it will issue its 2008 Financial Guidance prior to the market open on Monday, January 28, 2008. In addition to issuing a press release, Paul Herendeen, Executive Vice President and Chief Financial Officer will host a conference call and audio webcast to discuss the 2008 Financial Guidance for all interested parties at 8:30 a.m. EST on Monday, January 28, 2008.

SAN JOSE, California, January 22 /PRNewswire/ --

Atmel(R) Corporation (Nasdaq: ATML) announced today its AVR(R)32 UC3 microcontrollers have been named by EDN magazine to the list of products recognized in its annual Hot 100 Products issue at the end of 2007. The AT32UC3 32-bit Flash microcontrollers feature DSP instructions and have established new standards for computation efficiency and an industry leader for low power consumption of 1.3 mW per MHz for 32-bit microcontrollers.

INDIANAPOLIS, Indiana, January 22 /PRNewswire/ --

- Cheetah Medical Inc. Introduces New System to Measure Accurately, and Non-invasively Patients' Cardiac Output and Other Hemodynamic Parameters

Cheetah Medical Inc. announces the U.S. Food and Drug Administration (FDA) approved for marketing the Reliant, a highly accurate, portable cardiac output monitor which provides a noninvasive window to cardiac and hemodynamic function. The Reliant monitor is powered by Cheetah's unique, patented BIOREACTANCE(R) Technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.

About the Reliant Technology

SAN FRANCISCO and DUBLIN, Ireland, January 22 /PRNewswire/ --

Digital Realty Trust, Inc. (NYSE: DLR), a leading owner and manager of corporate datacenters and Internet gateways, announced today the signing of two major leases totaling approximately 210,500 square feet at projects in Santa Clara, California and Dublin, Ireland.

NAPERVILLE, Illinois, January 22 /PRNewswire/ --

- Announces plan to reduce annual costs and operating expenses by US$100 million

Tellabs reported fourth-quarter 2007 revenue of US$469 million, up 3% from US$455 million in the fourth quarter of 2006. For the year 2007, Tellabs revenue totaled US$1.9 billion, down 6% from US$2.0 billion in 2006.